• Assistant Professor, Neurology, CWRU School of Medicine

(216)844-3192

  • Gender: Male

Bio

Hesham Abboud, MD, PhD is the Director of the Multiple Sclerosis and Neuroimmunology Program at University Hospitals Cleveland Medical Center and a staff neurologist in the Parkinson’s & Movement Disorders Center. He is an Assistant Professor of Neurology at Case Western Reserve University School of Medicine.

Dr. Abboud is board-certified in neurology. His special interests include MS, NMO, autoimmune encephalitis, autoimmune movement disorders, spinal movement disorders, spasticity management, and neuromodulation.

Dr. Abboud earned his medical degree from Alexandria University in Egypt, where he also completed an internship and a residency in Neurology and Psychiatry. He obtained Master’s and Doctorate degrees in Neurology from Alexandria University before joining the Cleveland Clinic, where he completed a residency in adult neurology, a clinical fellowship in movement disorders and neuromodulation, and a clinical fellowship in multiple sclerosis and neuroimmunology. He received special training in transverse myelitis and neuromyelitis optica at the Transverse Myelitis Center of Johns Hopkins University.

Dr. Abboud is invested in medical education. He was selected as the medical student liaison for Neurology clerkship at the Cleveland Clinic during his residency and was appointed as a clinical instructor of neurology at the Cleveland Clinic Lerner College of Medicine. He received the Trainee Teacher of Year Award and the Excellence in Teaching Award from the Cleveland Clinic in 2015.

Dr. Abboud has written several peer-reviewed articles, abstracts and book chapters in the fields of neuroimmunology and movement disorders. He has presented his research in many international and national conferences and has won several research awards and travel grants from professional societies such as the American Academy of Neurology, the American Committee for Treatment and Research in Multiple Sclerosis, the Consortium of Multiple Sclerosis Centers, and The International Movement Disorders Society. In addition, Dr. Abboud has served as a reviewer for a number of prominent medical journals including Neurology, the International Journal of MS Care, Multiple Sclerosis: ETC, The American Journal of Psychiatry, among others. He is a member of the American Academy of Neurology, The NMO International Clinical Consortium, the Autoimmune Encephalitis Alliance, and the Movement Disorder Society.

Board Certifications

American Board of Psychiatry and Neurology - Neurology

Education & Training

Medical / Professional School(s)

2002, Alexandria University Hospitals

Residency

2007, Neurology - Alexandria University Hospitals
2015, Neurology - Cleveland Clinic

Fellowship

2011, Movement Disorders - Cleveland Clinic
2016, Neuroimmunology - Cleveland Clinic

Expertise

Multiple Sclerosis, Neuromyelitis Optica (NMO), Acute Disseminated Encephalomyelitis (ADEM), Transverse Myelitis, Dystonia, Chorea, Tremor, Baclofen Pump, Spasticity, Neuroimmunology, Autoimmune Encephalitis, Botulinum Toxin Injections, Parkinsonism, Movement Disorders, Paraneoplastic Encephalitis, Myoclonus, Tics, Deep Brain Stimulation

Office Locations

UH Cleveland Medical Center
(216)844-3192
Department of Neurology
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

Patient Satisfaction Reviews

About Our Survey

At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.

Learn More

Patient Comments

There are no comments for this practitioner.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Hesham Abboud, MD did not disclose any Outside Relationships with Industry.


There is no publicly available rating for this medical professional because he or she either does not see patients or has not yet received the minimum number of Patient Satisfaction Reviews. To be eligible for display, we require a minimum of 30 surveys. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.

UH Quality Care Network, is a collaboration among independent and UH employed providers. The focus is on improving the quality and efficiency of care, as well as reducing the cost of care.